Interpreting interest in interferon-α

Arthritis Research and Therapy

Volumn 5, Issue 5, 2003, Pages 246-248

  Thibault, Donna L ^a   Utz, Paul J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; DNA ANTIBODY; DOUBLE STRANDED DNA; GAMMA INTERFERON; INTERFERON; MESSENGER RNA;

ARTICLE; CELL STIMULATION; CLINICAL STUDY; CONNECTIVE TISSUE DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATOMYOSITIS; DRUG APPROVAL; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERFERON INDUCTION; MEDICAL DECISION MAKING; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TARGET CELL; UNITED STATES;

ANIMALS; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0141761540     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tan E, Cohen A, Fries J, Masi A, McShane D, Rothfield N, Schaller J, Talal N, Winchester R: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1272-1277.
2. Isaacs A, Lindemann J: Virus interference. I. The interferon. Proc Roy Soc B 1957, 147:258-267.
3. Merigan T, Reed S, Hall T, Tyrrell D: Inhibition of respiratory virus infection by locally applied interferon. Lancet 1973, 1: 563-567.
4. Brassard D, Grace M, Bordens R: Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol 2002, 71:565-581.
5. Nagata S, Mantei N, Weissmann C: The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature 1980, 287:401-408.
6. Taniguchi T, Mantei N, Schwarzstein M, Nagata S, Muramatsu M, Weissmann C: Human leukocyte and fibroblast interferons are structurally related. Nature 1980, 285:547-549.
7. Adolf G: Antigenic structure of human interferon omega1 (interferon alpha II): comparison with other human interferons. J Gen Virol 1987, 68:1669-1676.
8. Gray P, Leung D, Pennica D, Yelverton E, Najarian R, Simonsen C, Derynck R, Sherwood P, Wallace D, Berger S, Levinson A, Goeddel D: Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 1982, 295:503-508.
9. Merigan T: Induction of circulating interferon by synthetic anionic polymers of known composition. Nature 1967, 214: 416-417.
10. Merigan T: Interferons of mice and men. N Engl J Med 1967, 276:913-920.
11. Janeway C, Travers P, Walport M, Shlomchick M: Immunobiology, 5th ed. New York, London: Garland Publishing; 2001.
12. Hooks J, Moutsopoulos H, Geis S, Stahl N, Decker J, Notkins A: Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979, 301:5-8.
13. Ytterberg S, Schnitzer T: Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982, 25: 401-406.
14. Bengtsson A, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, Ronnblom L: Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000, 9:664-671.
15. Ronnblom L, Alm G, Oberg K: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991, 115:178-183.
16. Kalkner K, Ronnblom L, Karlsson Parra A, Bengtsson M, Olsson Y, Oberg K: Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon. QJM 1998, 91:393-399.
17. Ronnblom L, Alm G, Oberg K: Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990, 227:207-210.
18. Ioannou Y, Isenberg D: Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 2000, 43:1431-1442.
19. Blanco P, Palucka A, Gill M, Pascual V, Banchereau J: Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
20. Vallin H, Blomberg S, Alm G, Cederblad B, Ronnblom L: Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 1999, 115:196-202.
21. Vallin H, Perers A, Alm G, Ronnblom L: Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 1999, 163:6306-6313.
22. Rozzo S, Allard J, Choubey D, Vyse R, Izui S, Peltz G, Kotzin B: Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2001, 15:435-443.
23. Santiago-Raber M, Baccala R, Haraldsson K, Choubey D, Stewart T, Kono D, Theofilopoulos A: Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003, 197:777-788.
24. Braun D, Geraldes P, Demengeot J: Type I Interferon controls the onset and severity of autoimmune manifestations in Ipr mice. J Autoimmun 2003, 20:15-25.
25. Baechler E, Batliwalla F, Karypis G, Gaffney P, Ortmann W, Espe K, Shark K, Grande W, Hughes K, Kapur V, Gregersen P, Behrens T: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003, 100:2610-2615.
26. Bennett L, Palucka A, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723.
27. Tezak Z, Hoffman E, Lutz J, Fedczyna T, Stephan D, Bremer E, Krasnoselska-Riz I, Kumar A, Pachman L: Gene expression profiling in DQA1 *0501 + children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 2002, 168: 4154-4163.